Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio: 2011-2024

Historic Asset Utilization Ratio for Anika Therapeutics (ANIK) over the last 14 years, with Dec 2024 value amounting to 0.51.

  • Anika Therapeutics' Asset Utilization Ratio rose 71.04% to 0.60 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.60, marking a year-over-year increase of 71.04%. This contributed to the annual value of 0.51 for FY2024, which is 29.97% up from last year.
  • Latest data reveals that Anika Therapeutics reported Asset Utilization Ratio of 0.51 as of FY2024, which was up 29.97% from 0.39 recorded in FY2023.
  • Over the past 5 years, Anika Therapeutics' Asset Utilization Ratio peaked at 0.51 during FY2024, and registered a low of 0.33 during FY2022.
  • Over the past 3 years, Anika Therapeutics' median Asset Utilization Ratio value was 0.39 (recorded in 2023), while the average stood at 0.41.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first declined by 21.16% in 2022, then climbed by 29.97% in 2024.
  • Anika Therapeutics' Asset Utilization Ratio (Yearly) stood at 0.37 in 2020, then increased by 10.62% to 0.41 in 2021, then declined by 21.16% to 0.33 in 2022, then increased by 19.29% to 0.39 in 2023, then increased by 29.97% to 0.51 in 2024.